Dr. Jung-Sun Kim and Dr. C. Michael Gibson Discuss: ADAPT AF-DES – Appropriate Duration of Antiplatelet and Thrombotic Strategy after 12 Months in Patients with Atrial Fibrillation Treated with Drug-Eluting Stents November 8, 2025 2025 | Cardiology | Slides | Trial | Video Jung-Sun Kim_ADAPT AF-DES Trial (AHA 2025 LBCT) FinalDownload Disclosures: TBD Article Navigation Dr. Mary McDermott and Dr. C. Michael Gibson discuss the PERMET trial: Can metformin improve walking performance in nondiabetic patients with peripheral artery disease? Dr. Yohei Sotomi and Dr. C. Michael Gibson Discuss: OPTIMA-AF Trial – Short Dual Antithrombotic Therapy after PCI in Patients with Atrial Fibrillation: OPTIMA-AF trial
